MDSC: a new potential breakthrough in CAR-T therapy for solid tumors
Abstract Chimeric antigen receptor T (CAR-T) cell therapy has shown remarkable success in hematologic malignancies but has encountered challenges in effectively treating solid tumors. One major obstacle is the presence of the immunosuppressive tumor microenvironment (TME), which is mainly built by m...
שמור ב:
| Principais autores: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2024-12-01
|
| סדרה: | Cell Communication and Signaling |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1186/s12964-024-01995-y |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
